GlobeNewswire Inc.··Rosen Law FirmNektar Therapeutics Faces Securities Lawsuit Over REZOLVE-AA Trial Disclosures
Nektar Therapeutics faces securities class action lawsuit alleging false statements about REZOLVE-AA trial. Lead plaintiff deadline set for May 5, 2026.
NKTRsecurities class actionlead plaintiff